date:Dec 20, 2022
ccelerating toward a climate-neutral society.
Stock disequilibrium
The shareholders of Chr. Hansen will receive 1.5326 new B-shares in Novozymes per share after the merger, creating a 49% premium. After the announcement, Novozymes stock fell by 16%, while Chr. Hansen increased by 36%, according to Bloomberg.
The announcement unveiled expected annual revenue of 3.5 billion (US$3.72 billion) and detailed that annual revenue synergies are estimated to be 200 million (US$212.6 million).
Until 202